2010
DOI: 10.1111/j.1600-6143.2010.03248.x
|View full text |Cite
|
Sign up to set email alerts
|

The Quality of Health Insurance Service Delivery for Kidney Transplant Recipients: A Patient Perspective

Abstract: Increased attention has been devoted to improving quality care in kidney transplantation. The discourse on quality care has focused on transplant center metrics and other clinical parameters. However, there has been little discussion on the quality of health insurance service delivery, which may be critical to kidney recipients' access to transplantation and immunosuppression. This paper describes and provides a framework for characterizing kidney transplant recipients' positive and negative interactions with … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 14 publications
0
3
0
Order By: Relevance
“…It is also important to note that advocating for less complicated insurance pathways and more support from insurance companies might have an even larger impact on mitigating financial toxicity. 26 It is unrealistic to expect most patients to understand the intricacies of reimbursement and coverage in the US medical insurance system, especially while dealing with a life-changing diagnosis—thus, we hope that this study serves as a call to action for oncology clinicians to advocate on behalf of patients for policy changes that improve transparency and increase financial protections for people with cancer. Tangible changes like limiting out-of-pocket expenses, improving the preauthorization process, and reimbursing the nonmedical expenses that patients incur while undergoing treatment may do more to improve financial toxicity than any other intervention and should be pursued in conjunction with further intervention studies.…”
Section: Discussionmentioning
confidence: 99%
“…It is also important to note that advocating for less complicated insurance pathways and more support from insurance companies might have an even larger impact on mitigating financial toxicity. 26 It is unrealistic to expect most patients to understand the intricacies of reimbursement and coverage in the US medical insurance system, especially while dealing with a life-changing diagnosis—thus, we hope that this study serves as a call to action for oncology clinicians to advocate on behalf of patients for policy changes that improve transparency and increase financial protections for people with cancer. Tangible changes like limiting out-of-pocket expenses, improving the preauthorization process, and reimbursing the nonmedical expenses that patients incur while undergoing treatment may do more to improve financial toxicity than any other intervention and should be pursued in conjunction with further intervention studies.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, patients face challenges interacting with their insurance companies. 27 Patients with HMO coverage must contact their primary care provider to obtain authorization for their tests in order for insurance to approve the coverage; the myriad communications required in these arrangements may be especially demanding and time-consuming to navigate. It is highly plausible that these social risks and structural factors contributed to our Hispanic study population’s disproportionate inability to complete their work-up and testing, which prevented them from being presented to the KP committee and being waitlisted.…”
Section: Discussionmentioning
confidence: 99%
“…[45, 46, 48, 49] Together with a transplant surgeon (J.C.) a nationally recognized methodological expert (E.G. ), with training in medical anthropology and bioethics, who was hired from an outside institution in 2008 leads this team.…”
Section: Nutorc Teamsmentioning
confidence: 99%